AU2001264789A1 - Protein powder for pulmonary delivery - Google Patents

Protein powder for pulmonary delivery

Info

Publication number
AU2001264789A1
AU2001264789A1 AU2001264789A AU6478901A AU2001264789A1 AU 2001264789 A1 AU2001264789 A1 AU 2001264789A1 AU 2001264789 A AU2001264789 A AU 2001264789A AU 6478901 A AU6478901 A AU 6478901A AU 2001264789 A1 AU2001264789 A1 AU 2001264789A1
Authority
AU
Australia
Prior art keywords
protein powder
pulmonary delivery
pulmonary
delivery
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264789A
Inventor
Meenakshi Ganapati Bhat
George William Cuff
Ronald Keith Wolff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2001264789A1 publication Critical patent/AU2001264789A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001264789A 2000-06-08 2001-05-31 Protein powder for pulmonary delivery Abandoned AU2001264789A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21042300P 2000-06-08 2000-06-08
US60210423 2000-06-08
PCT/US2001/016472 WO2001093837A2 (en) 2000-06-08 2001-05-31 Protein powder for pulmonary delivery

Publications (1)

Publication Number Publication Date
AU2001264789A1 true AU2001264789A1 (en) 2001-12-17

Family

ID=22782843

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264789A Abandoned AU2001264789A1 (en) 2000-06-08 2001-05-31 Protein powder for pulmonary delivery

Country Status (2)

Country Link
AU (1) AU2001264789A1 (en)
WO (1) WO2001093837A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1797902A3 (en) * 2000-12-29 2007-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
DE10114178A1 (en) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinc-free and low-zinc insulin preparations with improved stability
JP4792457B2 (en) * 2004-03-26 2011-10-12 ユニヴァーシタ’デグリ ステュディ ディ パルマ Highly breathable insulin microparticles
US7772182B2 (en) 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
WO2008130220A1 (en) 2007-04-20 2008-10-30 N.V. Nutricia Process for dispersing amino acids
US8633152B2 (en) * 2007-08-07 2014-01-21 Nanomaterials Technology Pte Ltd Process for making micro-sized protein particles
KR20110084956A (en) 2008-10-17 2011-07-26 사노피-아벤티스 도이칠란트 게엠베하 Combination of an insulin and a glp-1 agonist
US20100183876A1 (en) * 2008-12-23 2010-07-22 Hell Andre Process for the Preparation of a Peptide Powder Form
RU2573995C2 (en) 2009-11-13 2016-01-27 Санофи-Авентис Дойчланд Гмбх Pharmaceutical composition containing glp-1 agonist and methionine
ES2534191T3 (en) 2009-11-13 2015-04-20 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine
BR112013004756B1 (en) 2010-08-30 2020-04-28 Sanofi Aventis Deutschland use of ave0010 for the manufacture of a medication for the treatment of type 2 diabetes mellitus
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
US9260503B2 (en) 2011-06-15 2016-02-16 Novo Nordisk A/S Multi-substituted insulins
SI2750699T1 (en) 2011-08-29 2015-11-30 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
AR099569A1 (en) 2014-02-28 2016-08-03 Novo Nordisk As INSULIN DERIVATIVES AND THE MEDICAL USES OF THESE
ES2841933T3 (en) 2014-10-31 2021-07-12 Univ Monash Powder formulation
PE20171622A1 (en) 2014-12-12 2017-11-02 Sanofi Aventis Deutschland INSULIN GLARGIN / LIXISENATIDE FIXED RATIO FORMULATION
TWI748945B (en) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 Treatment type 2 diabetes mellitus patients
TW201705975A (en) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 Treatment of type 2 diabetes mellitus patients
IL267520B2 (en) * 2016-12-22 2023-09-01 Kamada Ltd Dry powder formulations of alpha-1 antitrypsin
EP3897582B1 (en) 2018-12-21 2024-09-11 Novo Nordisk A/S Process of spray drying of glp-1 peptide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4323636A1 (en) * 1993-07-15 1995-01-19 Hoechst Ag Pharmaceutical preparations from coated, poorly water-soluble pharmaceutical substances for inhalation pharmaceutical forms and processes for their preparation
CZ92497A3 (en) * 1994-09-29 1997-08-13 Andaris Ltd Micro-particles of water soluble material intended for use in therapy or diagnosis, inhaling apparatus containing such particles and application of a therapeutical agent
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
AU764371B2 (en) * 1998-08-28 2003-08-14 Eli Lilly And Company Method for administering insulinotropic peptides
BR0004152A (en) * 1999-01-18 2000-11-21 Lg Chemichal Ltd Lipophilic microparticles containing a protein or antigen drug and prepared comprising the same

Also Published As

Publication number Publication date
WO2001093837A2 (en) 2001-12-13
WO2001093837A3 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
AU2001264789A1 (en) Protein powder for pulmonary delivery
AU2001232799A1 (en) Protein c derivatives
AU2001233201A1 (en) Dry powder inhaler
AU1409801A (en) Powder inhaler
AU2002223028A1 (en) Inhaler
AU6045900A (en) Interaction-activated proteins
AU2001295483A1 (en) Solid peptide preparations for inhalation, and the production thereof
AU2001232017A1 (en) Pharmaceutical composition for pulmonary delivery
AU3201701A (en) Pharmaceutical composition for pulmonary delivery
AU2002305903A1 (en) Carbohydrate-associated proteins
AU2002239291A1 (en) G protein coupled receptors
AU2001259450A1 (en) Cytoskeleton-associated proteins
AU2001296389A1 (en) Stable peptide formulations
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2001278975A1 (en) Alpha-conotoxin peptides
AU2002357850A1 (en) Neurotransmission-associated proteins
AU2001241044A1 (en) Mitf-associated proteins
AU2001278777A1 (en) Irap-binding protein
AU6444600A (en) New protein
AU2001232068A1 (en) Delivery capsules
AU7682600A (en) Sildenafil preparation
AU2001294911A1 (en) Carbohydrate-associated proteins
AU2001277614A1 (en) Novel proteins
AU2002326909A1 (en) Neurotransmission-associated proteins